Used as a key chiral intermediate in the synthesis of active pharmaceutical ingredients, particularly in the development of kinase inhibitors for targeted cancer therapies. Its stereochemistry enables selective interactions with biological targets, enhancing drug efficacy and reducing off-target effects. Commonly employed in the production of investigational oncology drugs where structural precision is critical for activity. Also utilized in medicinal chemistry research for optimizing pharmacokinetic properties of novel drug candidates.